Spire Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.91M | Sell |
11,298
-7,278
| -39% | -$3.16M | 0.18% | 109 |
|
|
2025
Q1 | $9.01M | Buy |
18,576
+72
| +0.4% | +$34.9K | 0.29% | 70 |
|
|
2024
Q4 | $7.45M | Sell |
18,504
-219
| -1% | -$88.2K | 0.23% | 92 |
|
|
2024
Q3 | $8.71M | Sell |
18,723
-1,031
| -5% | -$480K | 0.29% | 75 |
|
|
2024
Q2 | $9.25M | Sell |
19,754
-301
| -2% | -$141K | 0.33% | 62 |
|
|
2024
Q1 | $20.1M | Sell |
20,055
-596
| -3% | -$597K | 0.36% | 60 |
|
|
2023
Q4 | $8.98M | Buy |
20,651
+4,274
| +26% | +$1.86M | 0.3% | 71 |
|
|
2023
Q3 | $5.69M | Sell |
16,377
-6,796
| -29% | -$2.36M | 0.22% | 90 |
|
|
2023
Q2 | $8.15M | Sell |
23,173
-1,591
| -6% | -$560K | 0.3% | 72 |
|
|
2023
Q1 | $7.8M | Buy |
24,764
+3,664
| +17% | +$1.15M | 0.3% | 70 |
|
|
2022
Q4 | $6.09M | Sell |
21,100
-676
| -3% | -$195K | 0.34% | 67 |
|
|
2022
Q3 | $6.31M | Sell |
21,776
-5,276
| -20% | -$1.53M | 0.38% | 64 |
|
|
2022
Q2 | $7.62M | Sell |
27,052
-11,007
| -29% | -$3.1M | 0.31% | 83 |
|
|
2022
Q1 | $9.94M | Buy |
38,059
+35,416
| +1,340% | +$9.25M | 0.27% | 101 |
|
|
2021
Q4 | $580K | Buy |
2,643
+1,727
| +189% | +$379K | 0.01% | 642 |
|
|
2021
Q3 | $166K | Sell |
916
-450
| -33% | -$81.6K | ﹤0.01% | 996 |
|
|
2021
Q2 | $275K | Sell |
1,366
-3,362
| -71% | -$677K | 0.01% | 812 |
|
|
2021
Q1 | $1.02M | Buy |
+4,728
| New | +$1.02M | 0.03% | 431 |
|